Korean Health Stocks' Rising Valuations Worrying: Dalton
James Lim, senior research analyst at the $3 billion California-based hedge fund Dalton Investments LCC, discusses the outlook for South Korean stocks and corporate governance. Lim has warned that retail investors could pull out of the nation’s equity market on unforeseen events such as an earlier-than-expected curb in the Covid-19 pandemic or a lifting of a short-sell ban. Drug-related shares are especially vulnerable because hopes for a virus cure have made them expensive, according to Lim. He speaks on "Bloomberg Markets: Asia." (Source: Bloomberg)